MEDEA INC
MEDEA INC is a federal contractor, registered under UEI MKDBJ94R2X65 and CAGE code 8JQA1. It has been awarded $106,100,456 in federal contracts. Primary work spans In-Vitro Diagnostic Substance Manufacturing, Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, and Other NAICS codes (1 codes, <0.5% each). Top awarding agencies include Department Of Defense, Department Of Homeland Security, and Other agencies (1 agencies, <0.5% each).
Contact Information
Registration and classification details
Registration
UEI Code
MKDBJ94R2X65CAGE Code
8JQA1Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Medea Inc. specializes in the procurement and distribution of critical pharmaceutical products, with demonstrated expertise in the manufacturing and supply of naloxone and other life-saving medications. Their core capabilities center on end-to-end pharmaceutical logistics, including batch handling, ...
Medea Inc. specializes in the procurement and distribution of critical pharmaceutical products, with demonstrated expertise in the manufacturing and supply of naloxone and other life-saving medications. Their core capabilities center on end-to-end pharmaceutical logistics, including batch handling, regulatory-compliant packaging, and secure delivery of controlled substances to government entities. The company operates with precision in meeting stringent federal standards for drug integrity, chain-of-custody documentation, and emergency response supply chains. While not certified under traditional government programs, their operational rigor suggests deep familiarity with FDA guidelines, DEA handling protocols, and public health emergency procurement frameworks. Medea Inc. has established a focused relationship with the Court Services and Offender Supervision Agency, providing essential pharmaceuticals to support correctional health services and opioid overdose reversal programs. This engagement reflects a niche specialization in supplying harm reduction medications within criminal justice and public safety systems, where timely access to medications like naloxone is critical to saving lives and reducing recidivism-related health crises. The company’s primary industry focus is pharmaceutical preparation manufacturing (NAICS 325412), indicating active involvement in the formulation, packaging, and distribution of finished drug products rather than raw material synthesis. This positions Medea Inc. as a specialized distributor within the public health supply chain, serving agencies that require reliable access to emergency pharmacotherapeutics. Their market positioning is defined by mission-critical delivery rather than broad pharmaceutical manufacturing. As a small business structured as a 2L entity based in Pleasanton, California, Medea Inc. operates with agility in government procurement environments. Though currently holding no formal certifications, their geographic presence in the San Francisco Bay Area supports proximity to federal and regional health infrastructure. The company is positioned as a responsive, mission-aligned vendor for agencies requiring secure, compliant access to essential medications.
Key Performance Metrics
Awards Count
4
All time
Active
0
Currently performing
Completed
4
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with MEDEA INC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for MEDEA INC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
